TP53 and thyroid gland undifferentiated (anaplastic) carcinoma: TP53 alterations causing inactivation of apoptosis and cell-cycle progression were also reported to be the most frequent (54.4%) in anaplastic thyroid carcinomas (ATCs) [28].